These findings may have significant physiological ramifications, as they suggest induction of Dio1 expression and activity during hepatosteatosis, and early NASH may play a preventive role in NAFLD progression. The gene discussed is DIO1; the disease is metabolic dysfunction-associated steatotic liver disease.